Importantly, Gao et al. observed that AT-I could inhibit MPTP/MPP+-mediated oxidative stress and ROS production in neuroblastoma cells by activating Nrf2, alleviating motor deficits in mice with Parkinson’s disease [55]. Here, NFE2L2 is linked to neuroblastoma.